TetraLogic Pharmaceuticals Corp
Change company Symbol lookup
Select an option...
TLOG TetraLogic Pharmaceuticals Corp
JPM-K JPMorgan Chase & Co
KLAC KLA Corp
CNVY Convey Health Solutions Holdings Inc
EBAY eBay Inc
PRLX Parallax Health Sciences Inc
AXS AXIS Capital Holdings Ltd
SPNS Sapiens International Corporation NV
SPCE Virgin Galactic Holdings Inc
BBLG Bone Biologics Corp
Go

Company profile

TetraLogic Pharmaceuticals Corporation is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing small molecule therapeutics in oncology, infectious diseases and autoimmune diseases. The Company's segment is the identification and development of novel small molecule therapies in oncology and infectious diseases. The Company has approximately two clinical-stage product candidates in development, such as birinapant and SHAPE. SHAPE is the Company's histone deacetylase (HDAC) inhibitor that it is developing for topical use for the treatment of early-stage cutaneous T-cell lymphoma (CTCL). The Company is also exploring studying SHAPE in alopecia areata, an autoimmune skin disease. SHAPE has been granted the United States orphan drug designation for CTCL. Birinapant is a small molecule therapeutic that mimics Second Mitochondrial Activator of Caspases (SMAC)-mimetic, which leads to apoptosis or cell-death in damaged cells.

Closing Price
$0.005
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.005
Day's Low
0.005
Volume
(Heavy Day)
Volume:
5,100

10-day average volume:
5,100
5,100

Aurora Cannabis Inc. Stock Rises Thursday, Still Underperforms Market

4:33 pm ET February 24, 2022 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Aurora Cannabis Inc. (ACB.T) rose 2.67% to $3.84 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 3.34% to 13,473.59 and the Dow Jones Industrial Average rising 0.28% to 33,223.83. The stock's rise snapped a four-day losing streak. Aurora Cannabis Inc. closed $8.24 short of its 52-week high ($12.08), which the company achieved on March 2nd.

The stock underperformed when compared to some of its competitors Thursday, as Cronos Group Inc. (CRON.T) rose 3.90% to $3.46 and Tilray Brands Inc. Cl 2 (TLRY) rose 4.40% to $6.17. Trading volume (6.8 M) eclipsed its 50-day average volume of 5.8 M.

Data source: Dow Jones Market Data, FactSet. Data compiled February 24, 2022.

-MarketWatch Automation

	

(END) Dow Jones Newswires

February 24, 2022 16:33 ET (21:33 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.